IT1405762B1 - Proteine ricombinanti con attivita' di inattivazione selettiva di proteine bersaglio - Google Patents

Proteine ricombinanti con attivita' di inattivazione selettiva di proteine bersaglio

Info

Publication number
IT1405762B1
IT1405762B1 ITPD2010A000356A ITPD20100356A IT1405762B1 IT 1405762 B1 IT1405762 B1 IT 1405762B1 IT PD2010A000356 A ITPD2010A000356 A IT PD2010A000356A IT PD20100356 A ITPD20100356 A IT PD20100356A IT 1405762 B1 IT1405762 B1 IT 1405762B1
Authority
IT
Italy
Prior art keywords
inactivity
activities
recombinant proteins
selective target
selective
Prior art date
Application number
ITPD2010A000356A
Other languages
English (en)
Inventor
Marco Bestagno
Lara Vecchi
Oscar R Burrone
Original Assignee
Icgeb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icgeb filed Critical Icgeb
Priority to ITPD2010A000356A priority Critical patent/IT1405762B1/it
Priority to PCT/IB2011/055274 priority patent/WO2012070008A2/en
Publication of ITPD20100356A1 publication Critical patent/ITPD20100356A1/it
Application granted granted Critical
Publication of IT1405762B1 publication Critical patent/IT1405762B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/80—Immunoglobulins specific features remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies
    • C07K2317/81—Immunoglobulins specific features remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies functional in the endoplasmatic reticulum [ER] or the Golgi apparatus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ITPD2010A000356A 2010-11-25 2010-11-25 Proteine ricombinanti con attivita' di inattivazione selettiva di proteine bersaglio IT1405762B1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITPD2010A000356A IT1405762B1 (it) 2010-11-25 2010-11-25 Proteine ricombinanti con attivita' di inattivazione selettiva di proteine bersaglio
PCT/IB2011/055274 WO2012070008A2 (en) 2010-11-25 2011-11-24 Recombinant proteins with a selective inactivation activity on target proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD2010A000356A IT1405762B1 (it) 2010-11-25 2010-11-25 Proteine ricombinanti con attivita' di inattivazione selettiva di proteine bersaglio

Publications (2)

Publication Number Publication Date
ITPD20100356A1 ITPD20100356A1 (it) 2012-05-26
IT1405762B1 true IT1405762B1 (it) 2014-01-24

Family

ID=43742916

Family Applications (1)

Application Number Title Priority Date Filing Date
ITPD2010A000356A IT1405762B1 (it) 2010-11-25 2010-11-25 Proteine ricombinanti con attivita' di inattivazione selettiva di proteine bersaglio

Country Status (2)

Country Link
IT (1) IT1405762B1 (it)
WO (1) WO2012070008A2 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2548784B2 (es) * 2014-09-22 2016-11-21 Universidade De Santiago De Compostela Proteína muNS capaz de formar inclusiones en el retículo endoplasmático, métodos de uso y usos de la misma
WO2022161502A1 (zh) * 2021-02-01 2022-08-04 羿尊生物医药（浙江）有限公司 一种靶向蛋白降解系统及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE05675B1 (et) 2000-07-07 2013-08-15 Applied Research Systems Ars Holding N.V. Meetod konformse haiguse diagnoosimiseks v?i tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade
AU2002248213A1 (en) 2000-12-19 2002-08-19 Hospital For Special Surgery Markers for disease susceptibility and targets for therapy
CA2492313A1 (en) 2002-07-11 2004-01-22 Eidgenoessische Technische Hochschule Zuerich Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases
WO2005034737A2 (en) 2003-10-09 2005-04-21 University Of Massachusetts Methods for diagnosing and treating endoplasmic reticulum (er) stress diseases
US8192986B2 (en) 2004-05-05 2012-06-05 Whitehead Institute For Biomedical Research Compositions and methods for treatment of protein misfolding diseases
EP1814578A2 (en) 2004-11-04 2007-08-08 University of Washington Compositions and methods for treatment of protein misfolding and protein aggregation diseases
US7442597B2 (en) 2005-02-02 2008-10-28 Texas Instruments Incorporated Systems and methods that selectively modify liner induced stress
WO2006091964A2 (en) 2005-02-25 2006-08-31 The Board Of Trustees Of The University Of Alabama For And On Behalf Of The University Of Alabama Regulators of protein misfolding and aggregation and methods of using the same
KR20080018874A (ko) 2005-04-27 2008-02-28 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. 인간 질병과 관련된 돌연변이 단백질의 분해 촉진을 위한물질 및 방법
US20070015577A1 (en) 2005-07-18 2007-01-18 Weistech Technology Co., Ltd. Joypad with a display unit
US7887803B2 (en) 2005-12-02 2011-02-15 Amorfix Life Sciences Methods and compositions to treat misfolded-SOD1 mediated diseases
KR20090019790A (ko) 2006-05-19 2009-02-25 더 스크립스 리서치 인스티튜트 단백질 미스폴딩의 치료
US20080118938A1 (en) 2006-09-06 2008-05-22 Lisbell Estrada Methods and Compositions for the Detection of Protein Folding Disorders
WO2008127680A2 (en) 2007-04-11 2008-10-23 The Jackson Laboratory Diagnosis and treatment of diseases caused by misfolded proteins
EP2185724A4 (en) 2007-08-08 2010-09-08 Univ Alabama PROTEIN AND NEUROPROTECTION FOLDING REGULATORS AND METHOD OF USE
WO2009061906A2 (en) 2007-11-06 2009-05-14 Mayo Foundation For Medical Education And Research Treating protein misfolding diseases

Also Published As

Publication number Publication date
WO2012070008A3 (en) 2012-11-15
WO2012070008A2 (en) 2012-05-31
ITPD20100356A1 (it) 2012-05-26

Similar Documents

Publication Publication Date Title
SMT201700025B (it) Proteine di fusione ad fc comprendenti nuovi raccordi o arrangiamenti
HK1223835A1 (zh) 濃縮蛋白製劑及其用途
CO7020851A2 (es) Proteínas y péptidos modificados
HRP20181210T1 (hr) Fuzijski protein koji sadrži interleukin 4 i interleukin 10
ZA201305611B (en) Pesticidal nucleic acids and proteins and uses thereof
DK2553090T3 (da) Termostabile phytasevarianter
IL222961A0 (en) Novel dna-dinding proteins and uses thereof
EP2709603A4 (en) MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS AND APPLICATIONS THEREWITH
BR112013011777A2 (pt) iluminadores planos direcionais
BR112013010834A2 (pt) polipeptídeos fator ix modificados e usos dos mesmos
BR112013021524A2 (pt) micro-organismos recombinantes e usos dos mesmos
SMT201500142B (it) Procedimento per la purificazione di proteine
EE01079U1 (et) Territooriumi ja selle perimeetri j„lgimise ssteem
DK3434775T3 (da) Protein med nukleaseaktivitet, fusionsproteiner og anvendelser deraf
BR112012030941A2 (pt) proteína de fusão tendo atividade de fator vii
BR112014004936A2 (pt) polipeptídeo glicosilado e composição de drogas contendo referido polipeptídeo
SMT201600147B (it) Metodi per migliorare l'espressione di proteine ricombinanti
DK2782598T3 (da) Rekombinante proteiner og terapeutiske anvendelser deraf
DK3173102T3 (da) FGFR-FC-fusionsprotein og anvendelse deraf
EP2631249A4 (en) FUSION PROTEIN WITH FACTOR IX EFFECT
BR112013012390A2 (pt) hidrolisado de proteína hidrofobizada
BR112013013158A2 (pt) peptídeos de tomm34 e vacinas incluindo os mesmos
BR302012001168S1 (pt) "configuração aplicada em farol"
IT1405762B1 (it) Proteine ricombinanti con attivita' di inattivazione selettiva di proteine bersaglio
DK2152881T3 (da) RumC-peptider med antimikrobiel aktivitet